#4911 on the rich list of 14,644 insiders
Kenneth Hoberman
Director at TG Therapeutics; Director at Nuvectis Pharma. Based in Fort Lee, New Jersey.
$21.5M
in disclosed stock, −$422K (−1.93%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4911th of 14,644
- Companies held
- 2
- Largest holding
- TGTX, 84.5% of total
- Latest SEC filing
- Jun 11, 2026
What the $21.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| TG Therapeutics TGTX Common Stock | Directly | 279,653 | $64.88 | $18.1M | 84.5% | Form 4, Jun 12, 2025 |
| Nuvectis Pharma NVCT Common Stock | Directly | 168,140 | $19.84 | $3.3M | 15.5% | Form 4, Jun 11, 2026 |
Share counts are the amounts Kenneth Hoberman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4908 | Helga Houston Senior Exec. V. P., Huntington Bancshares. Columbus, OH | $21.5M |
| 4909 | C. Richard Reese Director, Charles River Laboratories International. Wilmington, MA | $21.5M |
| 4910 | Dhananjay Prasanna Technology Lead, Block. Oakland, CA | $21.5M |
| 4911 | Kenneth Hoberman Director, TG Therapeutics. Fort Lee, NJ | $21.5M |
| 4912 | Jay Backstrom CHIEF EXECUTIVE OFFICER, Scholar Rock Holding. Cambridge, MA | $21.5M |
| 4913 | Jochen Zeitz President and CEO, Harley-Davidson. Milwaukee, WI | $21.5M |
| 4914 | Daryl Simm Co-President and Co-COO, Omnicom Group. New York, NY | $21.5M |
Other TG Therapeutics insiders
All TGTX insiders- Michael S. Weiss$634MCEO. #393 overall
- Sean A. Power$51.8MCFO. #2483 overall
- Yann Echelard$14.5MDirector. #6610 overall
- Daniel Hume$12.5MDirector. #7410 overall
- Laurence N. Charney$10.9MDirector. #8043 overall
- Sagar Lonial$6.1MDirector. #12612 overall
Questions
How much stock does Kenneth Hoberman own?
Kenneth Hoberman holds $21,479,784 in listed stock based on SEC filings and current prices, mostly TG Therapeutics (TGTX). That ranks 4911th on the Stock Rich List.
Is this Kenneth Hoberman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.